Landscape and progress of global COVID-19 vaccine development
HY Huang, SH Wang, Y Tang, W Sheng… - Human Vaccines & …, 2021 - Taylor & Francis
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
affected billions of lives globally, and the world hopes to end this epidemic by effective …
affected billions of lives globally, and the world hopes to end this epidemic by effective …
[HTML][HTML] Whole inactivated virus and protein-based COVID-19 vaccines
PJ Hotez, ME Bottazzi - Annual Review of Medicine, 2022 - annualreviews.org
The rapid development and deployment of mRNA and adenovirus-vectored vaccines
against coronavirus disease 2019 (COVID-19) continue to astound the global scientific …
against coronavirus disease 2019 (COVID-19) continue to astound the global scientific …
[HTML][HTML] Super-rapid race for saving lives by developing COVID-19 vaccines
The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people and …
[HTML][HTML] Learning from the past: development of safe and effective COVID-19 vaccines
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are …
elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are …
[HTML][HTML] Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)
DG Ahn, HJ Shin, MH Kim, S Lee, HS Kim… - … of microbiology and …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …
[HTML][HTML] A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
[HTML][HTML] Development of an inactivated vaccine against SARS CoV-2
The rapid spread of SARS-CoV-2 with its mutating strains has posed a global threat to safety
during this COVID-19 pandemic. Thus far, there are 123 candidate vaccines in human …
during this COVID-19 pandemic. Thus far, there are 123 candidate vaccines in human …
[HTML][HTML] Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19)
Abstract The coronavirus disease 2019 (COVID-19) pandemic has infected 673,010,496
patients and caused the death of 6,854,959 cases globally until today. Enormous efforts …
patients and caused the death of 6,854,959 cases globally until today. Enormous efforts …
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike protein induce robust T-and B-cell immune responses and …
J García-Arriaza, U Garaigorta, P Pérez… - Journal of …, 2021 - Am Soc Microbiol
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of the coronavirus disease 2019 (COVID-19) pandemic, are urgently …
causative agent of the coronavirus disease 2019 (COVID-19) pandemic, are urgently …
Vaccines against SARS-CoV-2 variants and future pandemics
T Park, H Hwang, S Moon, SG Kang, S Song… - Expert review of …, 2022 - Taylor & Francis
Introduction Vaccination continues to be the most effective method for controlling COVID-19
infectious diseases. Nonetheless, SARS-CoV-2 variants continue to evolve and emerge …
infectious diseases. Nonetheless, SARS-CoV-2 variants continue to evolve and emerge …